DHR

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Danaher Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 15, 2023 – (NYSE: DHR)

Retrieved on: 
Friday, September 8, 2023
Danaher Corporation, NEXT, COVID-19, Danaher, Growth, Fraud, DHR, Holding company, Security (finance)

NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Danaher Corporation.

Key Points: 
  • NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Danaher Corporation.
  • Shareholders who purchased shares of DHR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
  • DEADLINE: September 15, 2023 Shareholders should not delay in registering for this class action.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

DANAHER DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Danaher Corporation and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, September 14, 2023
Class Action Lawsuit, Professional Services, Legal, Vaccine, P.C, Biotechnology, Telephone, COVID-19, Danaher, Jeanne Eagels (film), DHR, Research, Person, Danaher Corporation, Projection, District court, Cepheid variable, Biophysical environment, Court, Growth, NYSE, News, Pharmaceutical industry, Diagnosis

Investors have until September 15, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until September 15, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Danaher designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide.
  • The Company is comprised of more than 20 operating companies organized under four segments: Biotechnology; Life Sciences; Diagnostics; and Environmental & Applied Solutions.
  • On April 25, 2023, Danaher issued a press release announcing its financial results for the first quarter of 2023.

Danaher Announces Quarterly Dividend

Retrieved on: 
Tuesday, September 12, 2023
Danaher Corporation, DHR, NYSE

WASHINGTON, Sept. 12, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common stock, payable on October 27, 2023 to holders of record on October 12, 2023.

Key Points: 

WASHINGTON, Sept. 12, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common stock, payable on October 27, 2023 to holders of record on October 12, 2023.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Baxter, Rain, and Danaher, and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, September 7, 2023
Vaccine, P.C, Biotechnology, Shareholder, Face, Baxter International, RAIN, Baxter, COVID-19, Survival, MANTRA, DHR, Research, Danaher Corporation, Projection, Biophysical environment, Growth, FDA, News, NYSE, Audit, Cryptocurrency, Pharmaceutical industry, Diagnosis

Following this news, Baxter shares fell $5.23 per share, or 11.5%, from $45.37 to close at $40.14 per share on February 9, 2023.

Key Points: 
  • Following this news, Baxter shares fell $5.23 per share, or 11.5%, from $45.37 to close at $40.14 per share on February 9, 2023.
  • Over the course of the Class Period, Baxter’s stock price declined by nearly 50%, eliminating billions of dollars in market capitalization.
  • For more information on the Rain class action go to: https://bespc.com/cases/RAIN
    Danaher designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide.
  • The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects.

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Danaher Corporation Investors with Losses to Secure Counsel Before Important September 15 Deadline in Securities Class Action – DHR

Retrieved on: 
Thursday, September 7, 2023
Titan, Class, COVID-19, DHR, Danaher Corporation, Advertising, Court, Growth, NYSE, I-Space (Chinese company), Insurance, Tobacco

WHAT TO DO NEXT: To join the Danaher class action, go to https://rosenlegal.com/submit-form/?case_id=17717 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Danaher class action, go to https://rosenlegal.com/submit-form/?case_id=17717 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Thorne HealthTech, Inc. (Nasdaq - THRN), RPT Realty (NYSE - RPT), Abcam plc (Nasdaq - ABCM)

Retrieved on: 
Wednesday, September 6, 2023
Agreement, Tripura Merger Agreement, Brodsky, Kimco Realty, Danaher, DHR, Danaher Corporation, NYSE, KIM, RPT Realty, RPT, Security (finance), Abcam

BALA CYNWYD, Pa., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.

Key Points: 
  • BALA CYNWYD, Pa., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations.
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the Agreement, Thorne will be acquired by L Catterton for $10.20 per share in cash for each share of Thorne.
  • Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits.

SHAREHOLDER ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 15, 2023 in the Class Action Filed on Behalf of Danaher Corporation (DHR) Shareholders

Retrieved on: 
Wednesday, September 6, 2023
Danaher Corporation, Telephone, COST, CLASS, COVID-19, Danaher, Growth, HOW, DHR, NYSE

NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Danaher Corporation (NYSE: DHR) alleging that the Company violated federal securities laws.

Key Points: 
  • NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Danaher Corporation (NYSE: DHR) alleging that the Company violated federal securities laws.
  • WHAT THIS MEANS TO YOU AS A SHAREHOLDER: If you have suffered a loss in Danaher you have until September 15, 2023 to petition the court for lead plaintiff status.
  • Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
  • HOW TO PROTECT YOUR FINANCIAL INTERESTS: For additional information about the DHR lawsuit, please contact J. Klein, Esq.

DANAHER CORPORATION (NYSE: DHR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Danaher Corporation

Retrieved on: 
Tuesday, September 5, 2023
LLP, Class, COVID-19, Danaher, DHR, Danaher Corporation, Projection, District court, Advertising, Complaint, Court, Growth, NYSE, News, Cryptocurrency, Security (finance), Pharmaceutical industry

Bernstein Liebhard LLP , a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Danaher Corporation (“Danaher” or the “Company”) (NYSE: DHR) between April 21, 2022 and April 24, 2023, inclusive (the “Class Period”).

Key Points: 
  • Bernstein Liebhard LLP , a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Danaher Corporation (“Danaher” or the “Company”) (NYSE: DHR) between April 21, 2022 and April 24, 2023, inclusive (the “Class Period”).
  • If you wish to serve as lead plaintiff, you must move the Court no later than September 15, 2023.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Danaher Corporation(DHR) Investors of a Class Action Lawsuit and Upcoming Deadline

Retrieved on: 
Tuesday, September 5, 2023
CASE, LLP, Telephone, COST, COVID-19, DHR, Danaher Corporation, Levi, The Company, CLASS, NEXT, Court, Growth, NYSE, Cryptocurrency

NEW YORK, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Danaher Corporation ("Danaher" or the "Company") (NYSE: DHR) of a class action securities lawsuit.

Key Points: 
  • NEW YORK, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Danaher Corporation ("Danaher" or the "Company") (NYSE: DHR) of a class action securities lawsuit.
  • CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Danaher investors who were adversely affected by alleged securities fraud between April 21, 2022 and April 24, 2023.
  • Follow the link below to get more information and be contacted by a member of our team:
    DHR investors may also contact Joseph E. Levi, Esq.
  • For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

Lifshitz Law PLLC Announces Investigations of Rain Oncology, Inc. (NASDAQ: RAIN), Danaher Corp. (NYSE: DHR), Bausch Health Companies, Inc. (NYSE: BHC), and AT&T Inc. (NYSE: T)

Retrieved on: 
Sunday, September 3, 2023
AT&T, Telephone, RAIN, COVID-19, Danaher, Lead, BHC, MANTRA, DHR, Advertising, Growth, FDA, Hewlett, Safety, Pharmaceutical industry, Online shopping, Bausch

If you are a RAIN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.

Key Points: 
  • If you are a RAIN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.
  • If you are a DHR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq.
  • The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780.
  • Prior results do not guarantee or predict a similar outcome with respect to any future matter.